HEMGENIX OPTIONS

Amount of qualified sufferers: CDEC talked about the uncertainty in the number of clients with moderately critical to critical hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some clients who are categorized as having moderate or reasonable disorder could possibly have a critical bleedi